3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1700
INDUSTRY
457
NIH
80
OTHER_GOV
56
NETWORK
45
FED
8
INDIV
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
2
Thoracic
1
Other hematologic neoplasm
1
Lymphoid
1
Genitourinary
1
Breast
1
Conditions
Urinary Bladder Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Lung Neoplasms
1
Colorectal Neoplasms
1
Adenocarcinoma
1
Interventions
sargramostim
1
pembrolizumab
1
Ipilimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDIV
×
Observational
×
Genitourinary
×
Clear all
NCT03695835
2020-07-22
NIRPA
Gary Onik MD
Completed
27 enrolled